<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<GBSeq>

    <GBSeq_locus>LY833199</GBSeq_locus>
    <GBSeq_length>1611</GBSeq_length>
    <GBSeq_strandedness>double</GBSeq_strandedness>
    <GBSeq_moltype>DNA</GBSeq_moltype>
    <GBSeq_topology>linear</GBSeq_topology>
    <GBSeq_division>PAT</GBSeq_division>
    <GBSeq_update-date>18-NOV-2020</GBSeq_update-date>
    <GBSeq_create-date>18-NOV-2020</GBSeq_create-date>
    <GBSeq_definition>KR 1020200018455-A/50: AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE</GBSeq_definition>
    <GBSeq_primary-accession>LY833199</GBSeq_primary-accession>
    <GBSeq_accession-version>LY833199.1</GBSeq_accession-version>
    <GBSeq_other-seqids>
      <GBSeqid>dbj|LY833199.1|</GBSeqid>
      <GBSeqid>pat|KR|1020200018455|50</GBSeqid>
      <GBSeqid>gi|1933463801</GBSeqid>
    </GBSeq_other-seqids>
    <GBSeq_keywords>
      <GBKeyword>KR 1020200018455-A/50</GBKeyword>
    </GBSeq_keywords>
    <GBSeq_source>Adeno-associated virus - 4</GBSeq_source>
    <GBSeq_organism>Adeno-associated virus - 4</GBSeq_organism>
    <GBSeq_taxonomy>Viruses; Monodnaviria; Shotokuvirae; Cossaviricota; Quintoviricetes; Piccovirales; Parvoviridae; Parvovirinae; Dependoparvovirus; Dependoparvovirus primate1</GBSeq_taxonomy>
    <GBSeq_references>
      <GBReference>
        <GBReference_reference>1</GBReference_reference>
        <GBReference_position>1..1611</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Scheel,M.</GBAuthor>
          <GBAuthor>Ravina,B.</GBAuthor>
        </GBReference_authors>
        <GBReference_title>AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE</GBReference_title>
        <GBReference_journal>KR1020200018455-A 50 19-FEB-2020 VOYAGER THERAPEUTICS, INC</GBReference_journal>
      </GBReference>
    </GBSeq_references>
    <GBSeq_comment>KN KR 1020197036981-A/50~AN KR 1020197036981~AD 2019-12-13~PN KR 1020200018455~PD 2020-02-19~AT AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE~AI Scheel, Maria|Ravina, Bernard~AA VOYAGER THERAPEUTICS, INC.~PR US 62/554,155=2017-09-05|US 62/520,084=2017-06-15~OS adeno-associated virus 4~TY DNA~FH Key Location/Qualifiers.</GBSeq_comment>
    <GBSeq_feature-table>
      <GBFeature>
        <GBFeature_key>source</GBFeature_key>
        <GBFeature_location>1..1611</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>1</GBInterval_from>
            <GBInterval_to>1611</GBInterval_to>
            <GBInterval_accession>LY833199.1</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>organism</GBQualifier_name>
            <GBQualifier_value>Adeno-associated virus - 4</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>mol_type</GBQualifier_name>
            <GBQualifier_value>unassigned DNA</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>db_xref</GBQualifier_name>
            <GBQualifier_value>taxon:57579</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
    </GBSeq_feature-table>
    <GBSeq_sequence>atgccggggttctacgagatcgtgctgaaggtgcccagcgacctggacgagcacctgcccggcatttctgactcttttgtgagctgggtggccgagaaggaatgggagctgccgccggattctgacatggacttgaatctgattgagcaggcacccctgaccgtggccgaaaagctgcaacgcgagttcctggtcgagtggcgccgcgtgagtaaggccccggaggccctcttctttgtccagttcgagaagggggacagctacttccacctgcacatcctggtggagaccgtgggcgtcaaatccatggtggtgggccgctacgtgagccagattaaagagaagctggtgacccgcatctaccgcggggtcgagccgcagcttccgaactggttcgcggtgaccaagacgcgtaatggcgccggaggcgggaacaaggtggtggacgactgctacatccccaactacctgctccccaagacccagcccgagctccagtgggcgtggactaacatggaccagtatataagcgcctgtttgaatctcgcggagcgtaaacggctggtggcgcagcatctgacgcacgtgtcgcagacgcaggagcagaacaaggaaaaccagaaccccaattctgacgcgccggtcatcaggtcaaaaacctccgccaggtacatggagctggtcgggtggctggtggaccgcgggatcacgtcagaaaagcaatggatccaggaggaccaggcgtcctacatctccttcaacgccgcctccaactcgcggtcacaaatcaaggccgcgctggacaatgcctccaaaatcatgagcctgacaaagacggctccggactacctggtgggccagaacccgccggaggacatttccagcaaccgcatctaccgaatcctcgagatgaacgggtacgatccgcagtacgcggcctccgtcttcctgggctgggcgcaaaagaagttcgggaagaggaacaccatctggctctttgggccggccacgacgggtaaaaccaacatcgcggaagccatcgcccacgccgtgcccttctacggctgcgtgaactggaccaatgagaactttccgttcaacgattgcgtcgacaagatggtgatctggtgggaggagggcaagatgacggccaaggtcgtagagagcgccaaggccatcctgggcggaagcaaggtgcgcgtggaccaaaagtgcaagtcatcggcccagatcgacccaactcccgtgatcgtcacctccaacaccaacatgtgcgcggtcatcgacggaaactcgaccaccttcgagcaccaacaaccactccaggaccggatgttcaagttcgagctcaccaagcgcctggagcacgactttggcaaggtcaccaagcaggaagtcaaagactttttccggtgggcgtcagatcacgtgaccgaggtgactcacgagttttacgtcagaaagggtggagctagaaagaggcccgcccccaatgacgcagatataagtgagcccaagcgggcctgtccgtcagttgcgcagccatcgacgtcagacgcggaagctccggtggactacgcggacagattggctagaggacaacctctctga</GBSeq_sequence>
  </GBSeq>
